Beta Bionics (BBNX) Stock Price, Quote, News & History | Benzinga

SPY774.94+0.01%QQQ756.43+0.03%BTC/USD85,602.24−0.17%DIA512.59+0.09%GLD379.00−0.14%TLT77.13+0.03%

Beta Bionics Inc (BBNX) Stock Price, Quote, News & History

BBNXNASDAQ

Trade with Public

Trade with Public

$18.95

-0.01-0.05%

Last update: Oct 5, 4:00 PM

$18.95

-0.01-0.05%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$18.91

Close

$18.95

Volume / Avg.

624.63K / 1.28M

Day Range

$18.74 - $19.27

52 Wk Range

8.80 - 32.71

Market Cap

$1.02B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

19.76%

Days to Cover

9.91

Recent Beta Bionics, Inc. News

LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday

U.S. stocks mixed as Nasdaq rises; LuxExperience jumps 13.5% on strong sales, while Einride, Forgent, Cipher and others post gains.

Avi Kapoor

Beta Bionics, J.B. Hunt Transport And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

U.S. stock futures rose, but Beta Bionics fell 7.1% after pricing a stock offering; several other stocks also declined in premarket trading.

Avi Kapoor

Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket

Tempest shares surged 49.6% on a Senlang CD7 CAR-T option deal, while several small-cap stocks posted sharp premarket gains and losses.

Avi Kapoor

FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking

The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and ketones continuously for diabetes patients.

Vandana Singh

Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics

William Blair initiates coverage on Tandem Diabetes Care and Beta Bionics, highlighting their growth potential in the insulin pump market.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-55.81M

Investing Cash Flow (TTM)

58.92M

Financing Cash Flow (TTM)

6.14M

Free Cash Flow (TTM)

-61.41M

Capital Expenditure (TTM)

-5.60M

Net Change in Cash (TTM)

9.24M

Analyst Trends and Forecast

4

Apr

1

1

May

3

Jul

1

Aug

4

2

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$848.84M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

7.04

PB Ratio (TTM)

3.99

Earnings Yield % (TTM)

-8.45%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.75

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$44.32M

Debt to Equity

0.03

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-